H. Stehle

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

M. Rezai, T. Fehm, S. Loibl, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ZORO: A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37).

S. Loibl, H. Sommer, B. Gerber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Value of electroencephalography for the differential diagnosis of neurosis and organic brain disease.

H. Stehle, 1953, Electroencephalography and clinical neurophysiology.

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

M. Rezai, T. Fehm, S. Loibl, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.